Class IA PI3K isoforms lead to differential signalling downstream of PKB/Akt
Open Access
- 20 December 2023
- journal article
- research article
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (2) , 210-219
Abstract
Objectives: The catalytic subunits of Class IA PI3K, p110α, p110β, and p110δ, phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP 2 ) into phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) on the plasma membrane. In cancer, these catalytic subunits are usually found to be altered or amplified. Because pan-PI3K inhibition results in systemic toxicities, finding specific targets for the ubiquitous PI3K isoforms offers considerable potential for enhancing the effectiveness of PI3K-targeted therapy. Methods: We aim to delineate the isoform-specific druggable targets of the PI3K by deleting PIK3CA (encoding p110α) and PIK3CB (encoding p110β) by Cre mediated excision and ectopically expressing p110α, p110β, or p110δ with or without myristoylation (Myr) tag in mouse embryonic fibroblasts (MEFs). Myr is a lipidation signal that translocates proteins to plasma membrane permanently. This translocation renders p110s constitutively activated as they remain in close proximity to PIP 2 on the membrane. Results: Unique and redundant Akt targets are identified downstream of different PI3K isoforms. mTORC1, one of the targets of fully-activated Akt, has been observed to be differentially regulated in MEFs upon expression of p110α or p110β. The varying dependencies on mTORC1 and Rac1 led us to analyse a potential scaffolding function of p110β with Rac1 to mediate phosphorylation and activation of mTOR using platforms for the modeling of biomolecular complexes. We also documented that p110α and p110β support cell cycle kinetics differentially. Conclusions: This study suggests differential regulation of protein translation, metabolism, cell cycle, and survival signaling downstream of unique p110 targets, underlying the importance of cancer treatment according to the deregulated p110 isoform.Keywords
This publication has 39 references indexed in Scilit:
- RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase IsoformsCell, 2013
- Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer CellsFrontiers in Oncology, 2013
- Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS)Advances in Biological Regulation, 2013
- FoxOs Inhibit mTORC1 and Activate Akt by Inducing the Expression of Sestrin3 and RictorDevelopmental Cell, 2010
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- Tyrosine phosphorylation: thirty years and countingCurrent Opinion in Cell Biology, 2009
- The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γProceedings of the National Academy of Sciences, 2008
- G‐protein‐coupled receptor phosphorylation: where, when and by whomBritish Journal of Pharmacology, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3KTrends in Immunology, 2007